Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Clinical trial NCT00250276 · COMPLETED

Trial details

NCT number: NCT00250276
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Papillomavirus Papillomavirus Vaccines

Start date: 2005-10-28
Primary completion: 2007-03-01
Enrollment: 798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.